In vascular smooth muscle cells (VSMCs), SOCs mediate Ca2+ entry pathways which are proposed to regulate contractility, proliferation and migration, and are considered therapeutic targets for cardiovascular diseases such as hypertension and atherosclerosis.1-3. This evidence concerns the gene CISH and Hypertension.